United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$131Mraised across 4 rounds since 2015, from 4 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
PremierReported by FinSMEsSEC filing: $45M sold, first sale May 2018
Source recordedSEC filing: $45M sold, first sale May 2018
No investor was named in the report.
From a historical funding recordSEC filing: $2.0M sold, first sale Dec 2015
From the SEC filings it signed: 4 on the team.
On the board, as filediBrian DanielsLawrence GozlanMichael SistenichSteven Gillis
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
ARCH Venture PartnersFidelity
5AM VenturesAlexandria Venture InvestmentsSchroder AdveqPremierUniversity of Tokyo EdgeMissing a round, or an investor who was in one? Tell us.
Nohla Therapeutics's investors include ARCH Venture Partners, Fidelity, 5AM Ventures, Alexandria Venture Investments and Schroder Adveq, and 2 more on record.
Nohla Therapeutics has raised $131M across 4 rounds since 2015.
Nohla Therapeutics's most recent round was a Series B of $56M in Jul 2018.
Its most recent round, $56M in Jul 2018, is also its largest on record.
Nohla Therapeutics's first round on record, in Nov 2016, was backed by ARCH Venture Partners.
Nohla Therapeutics's latest named round is a Series B, in Jul 2018.
Nohla Therapeutics is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
